不同来源的干细胞移植治疗骨质疏松症

ISSN:2811-051X(P)

EISSN:2811-0781(O)

语言:中文

作者
桂云利
文章摘要
骨质疏松症是一种主要以单位体积的骨量减少以及骨组织微结构的破坏引起的全身性骨代谢疾病。目前传统的治疗方法存在一些局限性,针对严重的骨密度减少和骨折风险的患者,基因干细胞移植治疗作为一种新型的治疗方法,已经在研究和临床实践中受到了广泛关注。本文参考国内外文献,针对不同来源的干细胞移植治疗骨质疏松的现状及干细胞移植的展望进行综述,旨在为干细胞治疗骨质疏松症提供一些临床参考价值。
文章关键词
干细胞移植;骨质疏松症;移植治疗
参考文献
[1] 王可可,李思淼,罗婕,等.骨质疏松症临床实践指南评价及药物综合价值研究[J].中国医院药学杂志,2015,40(1):91-98. [2] Si L, Winzenberg T M, Jiang Q, et al. Projection of osteoporosis-related fractures and costs in China: 2010–2050[J]. Osteoporosis International,2015,26(34):1929-1937. [3] Zakrzewski W, Dobrzyński M, Szymonowicz M, et al. Stem cells: past, present, and future[J]. Stem cell research & therapy,2019,10(1):1-22. [4] 樊志刚,王东.小鼠胚胎干细胞移植治疗骨质疏松症[J].中国组织工程研究,2015,19(6):898. [5] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. cell,2006,126(4):663-676. [6] Xiaolin L , Qing L , Xin N ,et al.Exosomes Secreted from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Osteonecrosis of the Femoral Head by Promoting Angiogenesis[J].International Journal of Biological Sciences,2017,13(2):232-244. [7] Cha B H, Jung M J, Moon B K, et al. Administration of tauroursodeoxycholic acid enhances osteogenic differentiation of bone marrow-derived mesenchymal stem cells and bone regeneration[J]. Bone,2016,83(34):73-81. [8] 刘易昕,何强,张大鹏,等.大鼠骨质疏松模型的建立及其骨髓间充质干细胞内差异lncRNA初步分析[J].南京医科大学学报(自然科学版),2022,42(1):30-34. [9] 冯皓,张斌,王建平.骨髓间充质干细胞移植可提高骨质疏松大鼠骨代谢水平[J].中国组织工程研究,2023,27(1):72. [10] Rao R R, Stegemann J P. Cell-based approaches to the engineering of vascularized bone tissue[J]. Cytotherapy, 2013,15(11): 1309- 1322. [11] Wang F, Wang Q, Zhao Y, et al. Adipose-derived stem cells with miR-150-5p inhibition laden in hydroxyapatite/tricalcium phosphate ceramic powders promote osteogenesis via regulating Notch3 and activating FAK/ERK and RhoA[J]. Acta Biomaterialia,2023,155(34):644-653. [12] Fu Y S, Lu C H, Chu K A, et al. Xenograft of human umbilical mesenchymal stem cells from Wharton’s jelly differentiating into osteocytes and reducing osteoclast activity reverses osteoporosis in ovariectomized rats[J]. Cell transplantation,2018,27(1):194-208. [13] 向倩如,邓学健,陈华锋,等.基因修饰干细胞治疗骨质疏松:临床前研究的Meta分析[J].中国组织工程研究,2022,26(31):5053. [14] 柏小金,黄文良,柏帆,等.骨保护素基因修饰的骨髓间充质干细胞治疗大鼠骨质疏松[J].中国老年学杂志,2019,39(13):3245-3249.
Full Text:
DOI